Europe Romiplostim Market Report 2024

Europe Romiplostim Market Report 2023 Market Size Split by Type (250 μg/0.5 mL, 500 μg/1 mL), Application (Adults, Pediatric Patients), End-User (Hospitals, Clinics, Homecare), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Europe Romiplostim Market Report Description

Read a Detailed Qualitative analysis of the above report by requesting the free sample pages from Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Romiplostim Market

Key players deploy strategic initiatives such as product innovations, partnerships, and mergers. Companies prioritize R&D to introduce cutting-edge reagents, ensuring a competitive edge. Robust distribution networks and adherence to quality standards amplify market presence, fostering an environment where agility and innovation define industry leaders.

Romiplostim Industry News

In November 2012, Amgen announced that Nplate(TM) (romiplostim) is given marketing authorization in the European Union (EU) based on a positive judgement from the European Committee for Medicinal Products for Human Use (CHMP). For adults with splenectomized chronic immune thrombocytopenia purpura (ITP) who are not responding to alternative therapies, such as corticosteroids or immunoglobulins, the CHMP suggests Nplate. When surgery is not recommended, nplate may be used as a second line of treatment for adult non-splenectomized patients.

In October 2022, according to European Medicines Agenc, Nplate was proven to be beneficial for treating long-standing ITP in two major adult studies and a third study including children. In every study, Nplate was contrasted with a placebo, or fake treatment. The primary indicator of therapy efficacy for the patients, who had a 24-week course of treatment, was an increase in platelet count exceeding a threshold of 50 million platelets per millilitre of blood for at least six of the final eight weeks of treatment.

(Source: https://www.ema.europa.eu/en/medicines/human/EPAR/nplate)

Top Companies Market Share in Europe Romiplostim Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Europe Romiplostim Market Analysis

Type Segment Analysis of Europe Romiplostim Market

Europe Romiplostim market Type size and share analysis, have been revealed under this section. This section offers market size, revenue share, y-o-y growth rate along with market attractiveness for each type. This will help you to understand which type held largest revenue share along with its compound annual growth rate (CAGR) of Europe Romiplostim Market.

With the help of type segment analysis, companies can understand which type has potential to invest along with its driving factors, current trends and other key factors. The timeline covered in the published North America Report edition is 2019 to 2031.

Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!

Application Segment Analysis of Europe Romiplostim Market

Application segment analysis is key parameter for key companies and new entrants offering versatile products or services, helping them customize products to meet the need of different user scenarios. Based on the application segment analysis, key companies can choose which application segments to target in the Europe Romiplostim Market. Our experts continuously monitor market dynamics and consumer trends of the each application to evaluate the attractiveness and potential of each segment. In terms of revenue, we can also provide the cross split of types in the each application for year 2019-2031. To understand more please connect with our sales team.

Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!

Europe Romiplostim End-User Segment Analysis

• Hospitals
• Clinics
• Homecare

Europe Romiplostim Distribution Channel Segment Analysis

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Europe Romiplostim Country Analysis

In this section we have included market revenue, share, type, application and other segment analysis for each country level. Our team identifies and analyses potential risks associated with operating in each country, including rules and regulations, geopolitical risks, and other market-specific challenges. We estimate historical data and forecast future trends to understand the market's current situation in each country. This analysis helps key players to build strategies to strengthen their foothold in Europe Romiplostim market.

• United Kingdom
• France
• Germany
• Italy
• Russia
• Spain
• Sweden
• Denmark
• Netherlands
• Switzerland
• Belgium
• Rest of Europe

The Current Published report Editon on the website includes the following list of countries analysis whereas in case you looking to access any other country or states level data under Europe then please revert us to access the exclusive Europe Romiplostim industry report Edition.

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Bio :

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare indust...Read More

Author's Conclusion

• Author say's: Europe accounted for a share of over 30% of the global market size of USD XX million and projected to expand at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2031.
• The adult segment is boosting the market growth due to the second or third line of treatment for primary immune thrombocytopenia (ITP), romiplostim is recommended for adults.
• Romiplostim is recommended for paediatric patients who do not react to first-line treatment or who develop a steroid dependency due to its efficacy and safety features.
• The hospital held the highest romiplostim market revenue share in 2024.

Frequently Asked Questions

What is Europe Romiplostim market size/share and growth rate?

Europe Romiplostimmarket size and its growth rate has been provided in the report. The historical period included in the report is from 2019 to 2023, whereas, the report provides forecast data for the years 2023 to 2030. This will help you to in terms of market share, regional market share, country level market share to understand how the market has been performing in the past and how it is going to perform in the following years. Correspondingly, historical and forecast analysis comprises sales and revenue data of the Europe Romiplostimmarket. Market size for UK, Europe, North America, Asia Pacific, Middle East & Africa is also included in the report.

What are the major factors affecting the Europe Romiplostim market?

The major factors affecting the Europe Romiplostim market in a positive, as well as negative perspective, have been provided with detailed analysis in the report. This segment has encompassed drivers, opportunities, and challenges faced by the industry. This will help you to understand the major factors impacting Europe Romiplostim market trends and develop your business strategy accordingly.

Who are the top manufacturers of Europe Romiplostim? List of Europe Romiplostim Companies and there market trend or market share?

Major manufacturers or list of Europe Romiplostim manufacturers 2023 involved in the market have been profiled in the report along with their business strategies, recent developments, SWOT analysis, business overview, and market Trend from the year 2018-2022. Europe Romiplostim Companies such as are part of the final deliverable document along with the same we can provide data for 2nd, 3rd, start-up level companies data and strategies as well. This will help you to understand the competitive analysis of the market and how other players are performing in the market. This detailed competitive analysis will help you to strategize your business accordingly and will keep you one step ahead. A quantitative and qualitative analysis of the main players in the Europe Romiplostim market is introduced, from the perspective of sales, revenue and price.

Which segments are covered under Europe Romiplostim market segments analysis?

Under Europe Romiplostim market segments analysis Type, Application, End-User. It provides detailed insights on each type and application. Further, it provides which sub-segment is dominating the Europe Romiplostim market along with its reason. Additionally, the Europe Romiplostim market report will help you to analyze which sub-segment is fastest-growing during the forecast period.

What has been the impact of COVID-19 on the Europe Romiplostim market?

After the analysis of the complete market, the report has provided how the COVID-19 pandemic has affected the market. All the parameters have covered the overall impact of COVID -19 on the market value, market trend & growth of the market, and how the major players in the particular market are adopting these changes. This will help you to understand the overall optimistic, pessimistic, and neutral effects of the coronavirus pandemic on the Europe Romiplostim market.

How the Europe Romiplostim market performed till 2023 and how will it perform in the following years?

The Europe Romiplostim market has been analyzed thoroughly and has estimated the parameters which have affected the market in the historical period as well as how the market is going to perform in the following years. This will provide a complete market scenario and help you to strategize your next move accordingly to the Europe Romiplostim market Share.

Which region is expected to hold the highest market share in the Europe Romiplostim market?

The report gives an exhaustive investigation of the Europe Romiplostim market at country & regional levels, and provides an analysis of the industry trends in each of the regions, from sales, revenue, and consumption. It will help you to understand which region is dominating the market and is expected to grow significantly in the following years. The regional analysis will help you in strategizing the expansion of business.

What are the parameters used to analyze market position?

Europe Romiplostimmarket report has provided PESTEL and Porter analysis to provide insightful information regarding the market scenario. It also provides market attractiveness analysis with an acknowledgment of various factors within the market, including growth rate and market size, as well as outside factors such as access to raw materials, competition, and industry capacity.

How to order Full Report or Sample pages of the Europe Romiplostim market?

The sample report for the Europe Romiplostim Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.